alexa Immunogenicity of DNA vaccines in humans: it takes two to tango.
Immunology

Immunology

Journal of Vaccines & Vaccination

Author(s): Lu S

Abstract Share this page

Abstract Two recently completed phase I clinical trials with candidate HIV-1 vaccines demonstrated that DNA vaccines are, indeed, immunogenic in humans, even when administered through routine needle injections. However, the best use of this evolving technology lies in its potential to prime the host's immune system. Since the discovery of DNA immunization as a new method of vaccination in the early 1990s, the real value of this technology for human vaccine development was questioned due to the apparent poor immunogenicity in repeated early phase clinical studies when DNA plasmids were injected into humans by conventional needle injections. New results indicate that DNA vaccination can provide excellent priming effects to the human immune system, and high level, antigen-specific antibody and T cell immune responses are elicited upon further stimulation through the employment of a different form of vaccine which contains antigens that match those included in the original priming DNA vaccine formulation. These findings in no way will reduce the value of DNA vaccines, instead, the roles of DNA vaccines should be redefined. It is very likely that DNA vaccine can be most useful by providing an antigen-specific immunologic help to other types of vaccines that are known to have low immunogenicity, including inactivated or recombinant protein-based subunit vaccines.
This article was published in Hum Vaccin and referenced in Journal of Vaccines & Vaccination

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords